# MTNB (Matinas Biopharma Holdings, Inc.) - SEC EDGAR Financial Statements

> Matinas Biopharma Holdings, Inc. reported $4.38M in total assets and a net loss of $6.92M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MTNB
- Markdown: https://convexityos.com/fundamentals/MTNB.md
- SEC CIK: 0001582554
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001582554&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$6.83M | Operating profit |
| Net Income | FY 2025 | -$6.92M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$7.28 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.94M | Total debt: $4.0K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $1.10M | $3.19M | $33K | $158K | $90K | $120K | $150K | $0 |
| Research & Development | $85K | $11.43M | $14.49M | $16.68M | $14.58M | $14.36M | $11.23M | $6.79M | $9.01M | $3.95M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | $8.26M |
| **Operating Income** | -$6.96M | -$24.59M | -$23.77M | -$24.59M | -$24.73M | -$24.21M | -$18.92M | -$14.65M | -$16.50M | -$8.26M |
| **EBITDA** | -$6.93M | -$24.23M | -$23.38M | -$24.25M | -$24.49M | -$23.98M | -$18.72M | -$14.43M | -$16.40M | -$8.20M |
| Income Before Tax | -$10.35M | -$24.33M | -$22.94M | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | -$80K | -- | -- | -- | -- | -- | $507K | $400K | -- |
| **Net Income** | -$10.35M | -$24.25M | -$22.94M | -$21.00M | -$23.28M | -$22.45M | -$17.37M | -$14.08M | -$15.49M | -$7.60M |
| Basic EPS | -$30.00 | -$74.70 | -$79.20 | -$75.00 | -$82.50 | -$90.00 | -$97.50 | -$112.50 | -$270.00 | -$157.50 |
| **Diluted EPS** | -$30.00 | -$74.70 | -$79.20 | -$75.00 | -$82.50 | -$90.00 | -$97.50 | -$112.50 | -$270.00 | -$157.50 |
| Basic Shares Outstanding | 364.9K | 324.4K | 289.7K | 289.1K | 280.2K | 262.5K | 193.6K | 130.8K | 120.6K | 76.9K |
| Diluted Shares Outstanding | 364.9K | 324.4K | 289.7K | 289.1K | 280.2K | 262.5K | 193.6K | 130.8K | 120.6K | 76.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | $0 | $0 | $0 | $85K | $2.38M |
| **Operating Income** | -$1.74M | -$1.55M | -$1.94M | -$1.60M | -$1.58M | -$1.84M | -$1.95M | -$8.47M |
| **EBITDA** | -$1.74M | -$1.55M | -$1.94M | -$1.60M | -$1.58M | -$1.82M | -$1.93M | -$8.38M |
| **Net Income** | -$1.76M | -$1.33M | -$1.92M | -$1.91M | -$1.53M | -$5.25M | -$1.66M | -$8.43M |
| Basic EPS | -$9.35 | -$3.15 | -$4.50 | -- | -$5.93 | -$15.45 | -$4.95 | -- |
| **Diluted EPS** | -$9.35 | -$3.15 | -$4.50 | -- | -$5.93 | -$15.45 | -$4.95 | -- |
| Basic Shares Outstanding | -- | 427.1K | 427.1K | -- | 362.4K | 339.1K | 339.1K | -- |
| Diluted Shares Outstanding | 950.6K | 427.1K | 427.1K | -- | 362.4K | 339.1K | 339.1K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.00M | $7.28M | $4.79M | $6.83M | $21.03M | $12.43M | $22.17M | $12.45M | $7.31M | $4.11M |
| Short-Term Investments | -- | -- | $8.97M | $21.93M | $28.59M | $46.25M | $5.60M | -- | -- | -- |
| **Cash & Short-Term Investments** | $4.00M | $7.28M | $13.76M | $28.76M | $49.62M | $58.68M | $27.77M | $12.45M | $7.31M | $4.11M |
| **Total Current Assets** | $4.08M | $8.03M | $15.54M | $34.53M | $50.99M | $61.55M | $29.92M | $13.09M | $7.96M | $4.57M |
| Property, Plant & Equipment, Net | $138K | $468K | $1.92M | $2.09M | $1.54M | $1.52M | $1.75M | $2.04M | $1.57M | $356K |
| Goodwill | -- | -- | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M |
| Intangible Assets | $2.26M | $2.26M | $3.02M | $3.02M | $3.02M | $3.02M | -- | -- | -- | -- |
| **Total Non-Current Assets** | $3.13M | $4.62M | $9.56M | $10.29M | $10.33M | $9.41M | $10.32M | $6.86M | $6.46M | $5.25M |
| **Total Assets** | $7.21M | $12.64M | $25.10M | $44.82M | $61.33M | $70.97M | $40.24M | $19.94M | $14.42M | $9.82M |
| Accounts Payable | $315K | $95K | $514K | $618K | $937K | $350K | $679K | $296K | $583K | $476K |
| Deferred Revenue (Current) | -- | -- | -- | $721K | -- | -- | -- | -- | $30K | $0 |
| **Total Current Liabilities** | $1.46M | $2.67M | $2.62M | $4.29M | $4.35M | $3.57M | $3.10M | $2.84M | $1.77M | $1.44M |
| **Total Non-Current Liabilities** | $915K | $2.38M | $3.24M | $3.90M | $4.48M | $3.67M | $4.09M | $962K | $1.97M | $1.22M |
| **Total Liabilities** | $2.38M | $5.05M | $5.86M | $8.18M | $8.83M | $7.24M | $7.19M | $3.80M | $3.74M | $2.67M |
| **Total Debt (incl. Leases)** | $1.35M | $2.89M | $3.56M | $4.12M | $4.70M | $3.75M | $4.2K | $6.28M | -- | -- |
| Common Stock | $1.0K | $1.0K | $22K | $22K | $22K | $20K | $16K | $11K | $9.3K | $5.8K |
| Retained Earnings | -$210.8M | -$199.8M | -$175.6M | -$152.6M | -$131.6M | -$107.5M | -$84.38M | -$65.94M | -$51.27M | -$35.18M |
| Accumulated Other Comp. Income | -- | -- | -$221K | -$824K | -$145K | $228K | -$1.0K | -- | -- | -- |
| **Total Stockholders' Equity** | $4.83M | $7.59M | $19.25M | $36.64M | $52.49M | $63.73M | $33.05M | $16.14M | $10.68M | $7.15M |
| Total Equity | $4.83M | $7.59M | $19.25M | $36.64M | $52.49M | $63.73M | $33.05M | $16.14M | $10.68M | $7.15M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.94M | $761K | $2.40M | $4.00M | $5.43M | $6.53M | $6.92M | $7.28M |
| **Cash & Short-Term Investments** | $1.94M | $761K | $2.40M | $4.00M | $5.43M | $6.53M | $6.92M | $7.28M |
| **Total Current Assets** | $2.12M | $1.14M | $2.81M | $4.08M | $5.65M | $7.27M | $7.55M | $8.03M |
| Property, Plant & Equipment, Net | -- | -- | $138K | $138K | $156K | $158K | $450K | $468K |
| Intangible Assets | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M | $2.26M |
| **Total Non-Current Assets** | $2.26M | $2.27M | $3.06M | $3.13M | $4.04M | $4.16M | $4.49M | $4.62M |
| **Total Assets** | $4.38M | $3.41M | $5.87M | $7.21M | $9.70M | $11.42M | $12.04M | $12.64M |
| Accounts Payable | $775K | $845K | $712K | $315K | $80K | $167K | $282K | $95K |
| **Total Current Liabilities** | $1.19M | $1.35M | $2.13M | $1.46M | $1.50M | $1.78M | $2.25M | $2.67M |
| **Total Non-Current Liabilities** | $258K | $262K | $726K | $915K | $1.74M | $1.97M | $3.51M | $2.38M |
| **Total Liabilities** | $1.45M | $1.61M | $2.85M | $2.38M | $3.23M | $3.75M | $5.76M | $5.05M |
| **Total Debt (incl. Leases)** | $4.0K | $6.0K | $1.19M | $1.35M | $2.33M | $2.53M | $2.71M | $2.89M |
| Common Stock | -- | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$222.9M | -$214.0M | -$212.7M | -$210.8M | -$208.9M | -$206.7M | -$201.5M | -$199.8M |
| **Total Stockholders' Equity** | $2.93M | $1.80M | $3.02M | $4.83M | $6.46M | $7.67M | $6.27M | $7.59M |
| Total Equity | $2.93M | $1.80M | $3.02M | $4.83M | $6.46M | $7.67M | $6.27M | $7.59M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.35M | -$24.25M | -$22.94M | -$21.00M | $23.30M | $22.40M | $17.40M | -$14.08M | -$15.49M | -$7.60M |
| Depreciation & Amortization | $32K | $365K | $385K | $337K | $244K | $231K | $206K | $218K | $101K | $53K |
| Stock-Based Compensation | $1.02M | $3.19M | $4.95M | $5.23M | $4.29M | $4.56M | $2.99M | $3.83M | $3.60M | $1.52M |
| Change in Payables | $220K | -$419K | -$103K | -$321K | $588K | -$329K | $384K | -$287K | $107K | -$22K |
| **Operating Cash Flow** | -$7.01M | -$15.88M | -$15.28M | -$19.16M | -$15.22M | -$17.37M | -$14.09M | -$10.32M | -$11.46M | -$6.12M |
| Capital Expenditure | -- | -- | -$218K | -$892K | -$260K | -$5.7K | -$406K | -$536K | -$942K | $0 |
| **Free Cash Flow** | -- | -- | -$15.50M | -$20.05M | -$15.48M | -$17.37M | -$14.50M | -$10.86M | -$12.40M | -$6.12M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Purchases of Investments | -- | -$8.44M | -- | -$9.48M | -$23.20M | -$72.11M | -$5.61M | -- | -- | -- |
| **Investing Cash Flow** | $335K | $9.21M | $13.24M | $4.88M | $16.77M | -$40.67M | -$6.01M | -$536K | -$942K | $0 |
| Common Stock Issued | -- | $9.18M | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $3.39M | $9.17M | -$7.0K | $79K | $6.96M | $48.05M | $29.85M | $15.87M | $15.60M | $7.00M |
| **Net Change in Cash** | -$3.29M | $2.50M | -$2.04M | -$14.20M | $8.51M | -$9.99M | $9.75M | $5.01M | $3.20M | $878K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.76M | -$1.33M | -$1.92M | -$1.91M | -$1.53M | -$5.25M | -$1.66M | -$8.43M |
| Depreciation & Amortization | $0 | $0 | $0 | $3.0K | -$1.0K | $12K | $18K | $90K |
| Stock-Based Compensation | $100K | $104K | $113K | $217K | $253K | $238K | $315K | $244K |
| Change in Payables | -$70K | $132K | $397K | $235K | -$86K | -$116K | $187K | -$254K |
| **Operating Cash Flow** | -$1.61M | -$1.84M | -$1.60M | -$1.51M | -$1.47M | -$2.02M | -$2.01M | -$3.51M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $500K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -- | -- | -- | $58K | $64K | $1.62M | $1.65M | -$1.0K |
| **Net Change in Cash** | $1.18M | -$1.84M | -$1.60M | -$1.44M | -$1.09M | -$399K | -$360K | -$3.01M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -2168.4% | -771.3% | -74954.5% | -15288.4% | -21067.4% | -12230.9% | -11024.6% | -- |
| **Net Profit Margin** | -- | -- | -2093.2% | -658.6% | -70554.5% | -14177.0% | -19343.4% | -11760.4% | -10345.9% | -- |
| Return on Equity (ROE) | -214.2% | -319.5% | -119.2% | -57.3% | -44.4% | -35.2% | -52.6% | -87.2% | -145.0% | -106.3% |
| Return on Assets (ROA) | -143.5% | -191.8% | -91.4% | -46.8% | -38.0% | -31.6% | -43.2% | -70.6% | -107.4% | -77.4% |
| Current Ratio | 2.79x | 3.01x | 5.93x | 8.06x | 11.73x | 17.25x | 9.66x | 4.61x | 4.50x | 3.16x |
| Quick Ratio | 2.73x | 2.73x | 5.25x | 6.71x | 11.41x | 16.45x | 8.97x | 4.38x | 4.13x | 2.84x |
| Debt to Equity | 0.28x | 0.38x | 0.18x | 0.11x | 0.09x | 0.06x | 0.00x | 0.39x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -65.6% | +9560.6% | -79.2% | +76.3% | -25.0% | -20.0% | -- | -100.0% |
| 5Y Revenue / Share Growth | -- | -- | +313.3% | +788.7% | -- | -78.7% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -236.5% | -371.7% | -351.1% | -214.2% | -261.1% | -255.5% | -320.3% | -319.5% |
| Return on Assets (ROA) | -158.1% | -196.1% | -180.6% | -143.5% | -174.0% | -171.6% | -166.9% | -191.8% |
| Current Ratio | 1.78x | 0.85x | 1.32x | 2.79x | 3.78x | 4.07x | 3.35x | 3.01x |
| Quick Ratio | 1.62x | 0.56x | 1.13x | 2.73x | 3.64x | 3.66x | 3.07x | 2.73x |
| Debt to Equity | 0.00x | 0.00x | 0.39x | 0.28x | 0.36x | 0.33x | 0.43x | 0.38x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
